Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|January 14, 2026
Graves' Disease: A New Era of Pathophysiology-Guided TherapeuticsMarius N Stan, David Toro-Tobon
European Journal of Endocrinology|August 12, 2025
The evolving landscape of thyroid eye disease: present and futureDavid Toro-Tobon, Marius N Stan
Thyroid : Official Journal of the American Thyroid Association|March 6, 2026
Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?Dana Hamadi, Suhail Saad-Omer, David Toro-Tobon, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 27, 2024
Impact of Teprotumumab on Clinical Practice in Thyroid Eye DiseaseKharisa N Rachmasari, David Toro-Tobon, Lilly H Wagner, et al.
Thyroid : Official Journal of the American Thyroid Association|July 29, 2023
Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye DiseaseDavid Toro-Tobon, Kharisa N Rachmasari, Elizabeth A Bradley, et al.
The Clinical Teacher|September 6, 2022
Awareness, perceptions, and characteristics of internal medicine residents as role modelsDavid Toro-Tobon, Sarah Thornton
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 14, 2024
Controversies in the Management of Intermediate-Risk Differentiated Thyroid CancerDavid Toro-Tobon, Juan P Brito
Women'S Health (London, England)|May 2, 2023
Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragilityAnnop Kittithaworn, David Toro-Tobon, Jad G Sfeir
Drugs|January 20, 2019
Current and Emerging Treatment Strategies for Graves' OrbitopathyNatalia Genere, Marius N Stan
Pageof 11